Abstract: The present disclosure provides novel (2R,3S)-2-(3-(4,5-dichloro-1H-benzo[d]imidazol-1 -yl)propyl)piperidin-3-ol monohydrochloride, (2R,3S)-2-(3-(4,5-dichloro-1H-benzo[d]imidazol-1 -yl)propyl)piperidin-3-ol oxalate, (2R,3S)-2-(3-(4,5-dichloro-1H-benzo[d]imidazol-1 -yl)propyl)piperidin-3-ol maleate, (2R,3S)-2-(3-(4,5-dichloro-1H-benzo[d]imidazol-1 -yl)propyl)piperidin-3-ol palmitate, and crystalline form of (2R,3S)-2-(3-(4,5-dichloro-1H-benzo[d]imidazol-1-yl)propyl)piperidin-3-ol monohydrochloride. These novel acid addition salts and crystalline forms have low hygroscopicity and excellent severe stability under high temperature and high humidity conditions, and thus can be used pharmaceutically.

Abstract: The present invention relates to a method for preparing (2R, 3S)-2-(benzo[d]imidazolylpropyl)piperidin-3-ol derivatives, and the preparation method according to the present invention has the advantage that the compound can be prepared in high yield even with a shortened process.

Abstract: The pharmaceutical composition according to the present invention can be usefully used for the prevention or treatment of systemic fibrosis.

Abstract: The present disclosure relates to a pharmaceutical composition that can be usefully used for the prevention or treatment of fibrosis. According to the present invention, there is a feature that the preventive or therapeutic effect of fibrosis can be further enhanced by using the first component and the second component in combination.

Abstract: The pharmaceutical composition according to the present invention is used at specific therapeutic regimen and dosage, and can be usefully used for the prevention or treatment of fibrosis.

Abstract: A cleaner for a lidar sensor may include: a blast pipe unit through which wind generated from a fan of an engine passes; and a lidar sensor installed in the blast pipe unit, wherein foreign matter adhering to the surface of the lidar sensor are removed by wind discharged from the blast pipe unit.

Abstract: A object detection apparatus may include: an object detection sensor having a cover for protecting the object detection sensor from foreign matter, and configured to sense a target object by transmitting a scan signal to the target object and receiving a sensing signal reflected from the target object; a protection film part including a protection film disposed on an outer surface of the cover to prevent contamination of the cover by foreign matter; and a control unit configured to replace the protection film disposed on the outer surface of the cover through a winding operation for the protection film part when a protection film replacement condition is satisfied due to contamination of the protection film, in order to prevent a reduction in sensing performance of the object detection sensor due to contamination by foreign matter.

Abstract: The present invention relates to a heterocyclic compound represented by Chemical Formula 1 that can be used for the prevention or treatment of diseases caused by abnormality in a PRS (prolyl-tRNA synthetase) activity, or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition comprising the same.

Abstract: A panel module including a display panel, a chips-on-film (COF) having a first end connected to an end portion of the display panel, and a COF cover configured to extend past the first end of the COF to block the first end of the COF, the cover having a front surface formed to be coplanar with a front surface of the display panel.

Abstract: The present invention relates to a heterocyclic compound represented by Chemical Formula 1 that can be used for the prevention or treatment of diseases caused by abnormality in a PRS (prolyl-tRNA synthetase) activity, or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition comprising the same.

Abstract: A object detection apparatus may include: an object detection sensor having a cover for protecting the object detection sensor from foreign matter, and configured to sense a target object by transmitting a scan signal to the target object and receiving a sensing signal reflected from the target object; a protection film part including a protection film disposed on an outer surface of the cover to prevent contamination of the cover by foreign matter; and a control unit configured to replace the protection film disposed on the outer surface of the cover through a winding operation for the protection film part when a protection film replacement condition is satisfied due to contamination of the protection film, in order to prevent a reduction in sensing performance of the object detection sensor due to contamination by foreign matter.

Abstract: A cleaner for a lidar sensor may include: a blast pipe unit through which wind generated from a fan of an engine passes; and a lidar sensor installed in the blast pipe unit, wherein foreign matter adhering to the surface of the lidar sensor are removed by wind discharged from the blast pipe unit.

Abstract: The present invention relates to a compound represented by chemical formula 1, which can be used for the prevention and treatment of diseases caused by abnormality in a prolyl-tRNA synthetase (PRS) activity, or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition comprising the same.

Abstract: The present invention relates to a heterocyclic compound having a novel structure that can be used in the prevention or treatment of diseases caused by abnormality in a PRS (prolyl-tRNA synthetase) activity, a method for preparing the same, and a pharmaceutical composition comprising the same.

Abstract: A panel module including a display panel, a chips-on-film (COF) having a first end connected to an end portion of the display panel, and a COF cover configured to extend past the first end of the COF to block the first end of the COF, the cover having a front surface formed to be coplanar with a front surface of the display panel.

Abstract: The present invention relates to a heterocyclic compound having a novel structure that can be used in the prevention or treatment of diseases caused by abnormality in a PRS (prolyl-tRNA synthetase) activity, a method for preparing the same, and a pharmaceutical composition comprising the same.

Abstract: The present invention relates to novel oxodihydropyridinecarbohydrazide derivatives with excellent antifungal activities, an antifungal composition containing the same, and its use for the prevention and treatment of fungal infectious diseases. The oxodihydropyridinecarbohydrazide derivatives of the present invention have excellent antifungal and fungicidal activities, and thus will be useful for the prevention and treatment of various fungal infections by Candida spp., Aspergillus spp., Cryptococcus neoformans and Trichophyton spp., etc. Additionally, the oxodihydropyridinecarbohydrazide derivatives of the present invention, unlike other fungicidal preparations, can be orally administered.

Abstract: The present invention relates to a compound represented by chemical formula 1, which can be used for the prevention and treatment of diseases caused by abnormality in a prolyl-tRNA synthetase (PRS) activity, or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition comprising the same.

Abstract: The present invention relates to novel oxodihydropyridinecarbohydrazide derivatives with excellent antifungal activities, an antifungal composition containing the same, and its use for the prevention and treatment of fungal infectious diseases. The oxodihydropyridinecarbohydrazide derivatives of the present invention have excellent antifungal and fungicidal activities, and thus will be useful for the prevention and treatment of various fungal infections by Candida spp., Aspergillus spp., Cryptococcus neoformans and Trichophyton spp., etc. Additionally, the oxodihydropyridinecarbohydrazide derivatives of the present invention, unlike other fungicidal preparations, can be orally administered.

Abstract: The present invention relates to a compound having a blocking effect against sodium ion channels, particularly Nav1.7, a preparation method thereof and the use thereof. A compound represented by formula 1 according to the invention, or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof may be effectively used for the prevention or treatment of pain, for example, acute pain, chronic pain, neuropathic pain, post-surgery pain, migraine, arthralgia, neuropathy, nerve injury, diabetic neuropathy, neuropathic disease, epilepsy, arrhythmia, myotonia, ataxia, multiple sclerosis, irritable bowel syndrome, urinary incontinence, visceral pain, depression, erythromelalgia, or paroxysmal extreme pain disorder (PEPD).